(ROL) Rollins - Ratings and Ratios
Pest Control, Termite Protection, Wildlife Services
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.14% |
| Yield on Cost 5y | 1.77% |
| Yield CAGR 5y | 14.33% |
| Payout Consistency | 91.0% |
| Payout Ratio | 61.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 23.1% |
| Value at Risk 5%th | 35.9% |
| Relative Tail Risk | -5.57% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.88 |
| Alpha | 16.53 |
| CAGR/Max DD | 0.71 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.243 |
| Beta | 0.281 |
| Beta Downside | 0.125 |
| Drawdowns 3y | |
|---|---|
| Max DD | 26.33% |
| Mean DD | 4.31% |
| Median DD | 2.91% |
Description: ROL Rollins December 17, 2025
Rollins, Inc. (NYSE: ROL) operates through subsidiaries that deliver pest- and wildlife-control services to both residential and commercial customers across the United States and select international markets. The firm’s portfolio includes routine pest management, termite protection, and ancillary services, and it serves clients directly as well as via a franchise network that accounts for roughly 30 % of total revenue.
Key performance indicators as of the most recent fiscal year show a revenue run-rate of about $3.2 billion, with a 5-year compound annual growth rate (CAGR) of 6 % and an operating margin hovering near 13 %, reflecting the high-margin nature of franchise-driven operations. Demand for pest control is relatively inelastic, making the business resilient to macro-economic downturns, while growth in the logistics and food-service sectors-driven by e-commerce expansion-provides a tailwind for commercial contracts.
For a deeper quantitative look, you might explore Rollins’ metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income (515.9m TTM) > 0 and > 6% of Revenue (6% = 220.8m TTM) |
| FCFTA 0.21 (>2.0%) and ΔFCFTA 1.87pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.41% (prev -4.09%; Δ -0.31pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.22 (>3.0%) and CFO 701.5m > Net Income 515.9m (YES >=105%, WARN >=100%) |
| Net Debt (784.7m) to EBITDA (840.8m) ratio: 0.93 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.77 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (484.7m) change vs 12m ago 0.06% (target <= -2.0% for YES) |
| Gross Margin 52.86% (prev 52.64%; Δ 0.22pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 121.9% (prev 117.6%; Δ 4.39pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 27.43 (EBITDA TTM 840.8m / Interest Expense TTM 26.1m) >= 6 (WARN >= 3) |
Altman Z'' 3.03
| (A) -0.05 = (Total Current Assets 550.7m - Total Current Liabilities 712.8m) / Total Assets 3.22b |
| (B) 0.28 = Retained Earnings (Balance) 905.5m / Total Assets 3.22b |
| (C) 0.24 = EBIT TTM 717.1m / Avg Total Assets 3.02b |
| (D) 0.81 = Book Value of Equity 1.36b / Total Liabilities 1.69b |
| Total Rating: 3.03 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 87.59
| 1. Piotroski 7.0pt |
| 2. FCF Yield 2.27% |
| 3. FCF Margin 18.34% |
| 4. Debt/Equity 0.60 |
| 5. Debt/Ebitda 0.93 |
| 6. ROIC - WACC (= 21.63)% |
| 7. RoE 36.45% |
| 8. Rev. Trend 88.76% |
| 9. EPS Trend 80.57% |
What is the price of ROL shares?
Over the past week, the price has changed by +2.50%, over one month by +2.59%, over three months by +8.00% and over the past year by +23.96%.
Is ROL a buy, sell or hold?
- Strong Buy: 2
- Buy: 2
- Hold: 7
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the ROL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 62.8 | 5.7% |
| Analysts Target Price | 62.8 | 5.7% |
| ValueRay Target Price | 70.7 | 18.8% |
ROL Fundamental Data Overview December 13, 2025
P/E Trailing = 55.6019
P/E Forward = 47.3934
P/S = 7.8507
P/B = 18.6833
P/EG = 3.8793
Beta = 0.785
Revenue TTM = 3.68b USD
EBIT TTM = 717.1m USD
EBITDA TTM = 840.8m USD
Long Term Debt = 485.7m USD (from longTermDebt, last quarter)
Short Term Debt = 134.2m USD (from shortTermDebt, last quarter)
Debt = 912.1m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 784.7m USD (from netDebt column, last quarter)
Enterprise Value = 29.68b USD (28.89b + Debt 912.1m - CCE 127.4m)
Interest Coverage Ratio = 27.43 (Ebit TTM 717.1m / Interest Expense TTM 26.1m)
FCF Yield = 2.27% (FCF TTM 675.0m / Enterprise Value 29.68b)
FCF Margin = 18.34% (FCF TTM 675.0m / Revenue TTM 3.68b)
Net Margin = 14.02% (Net Income TTM 515.9m / Revenue TTM 3.68b)
Gross Margin = 52.86% ((Revenue TTM 3.68b - Cost of Revenue TTM 1.73b) / Revenue TTM)
Gross Margin QoQ = 54.44% (prev 53.79%)
Tobins Q-Ratio = 9.22 (Enterprise Value 29.68b / Total Assets 3.22b)
Interest Expense / Debt = 0.87% (Interest Expense 7.94m / Debt 912.1m)
Taxrate = 24.79% (53.9m / 217.4m)
NOPAT = 539.3m (EBIT 717.1m * (1 - 24.79%))
Current Ratio = 0.77 (Total Current Assets 550.7m / Total Current Liabilities 712.8m)
Debt / Equity = 0.60 (Debt 912.1m / totalStockholderEquity, last quarter 1.53b)
Debt / EBITDA = 0.93 (Net Debt 784.7m / EBITDA 840.8m)
Debt / FCF = 1.16 (Net Debt 784.7m / FCF TTM 675.0m)
Total Stockholder Equity = 1.42b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.02% (Net Income 515.9m / Total Assets 3.22b)
RoE = 36.45% (Net Income TTM 515.9m / Total Stockholder Equity 1.42b)
RoCE = 37.72% (EBIT 717.1m / Capital Employed (Equity 1.42b + L.T.Debt 485.7m))
RoIC = 28.48% (NOPAT 539.3m / Invested Capital 1.89b)
WACC = 6.85% (E(28.89b)/V(29.81b) * Re(7.05%) + D(912.1m)/V(29.81b) * Rd(0.87%) * (1-Tc(0.25)))
Discount Rate = 7.05% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Shares Correlation 3-Years: 100.0 | Cagr: 0.06%
[DCF Debug] Terminal Value 80.08% ; FCFE base≈620.1m ; Y1≈707.0m ; Y5≈975.0m
Fair Price DCF = 35.05 (DCF Value 16.86b / Shares Outstanding 481.2m; 5y FCF grow 16.36% → 3.0% )
EPS Correlation: 80.57 | EPS CAGR: 27.68% | SUE: 1.70 | # QB: 1
Revenue Correlation: 88.76 | Revenue CAGR: 15.37% | SUE: 1.22 | # QB: 4
EPS next Quarter (2026-03-31): EPS=0.25 | Chg30d=+0.004 | Revisions Net=+1 | Analysts=9
EPS next Year (2026-12-31): EPS=1.28 | Chg30d=+0.010 | Revisions Net=+2 | Growth EPS=+12.0% | Growth Revenue=+9.3%
Additional Sources for ROL Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle